Health In Tech (HIT) Stock Price, News & Analysis

Company Overview

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

Key Stats

• Today's Range: $1.04 to $1.12
• 50-Day Range: $0.87 to $1.72
• 52-Week Range: $0.57 to $4.02
• Volume: 113,663 shs
• Average Volume: 295,856 shs
• Market Capitalization: $70.12 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.25
• Consensus Rating: Buy

Health In Tech Stock Analysis - MarketRank™

Health In Tech scored higher than 52% of companies evaluated by MarketBeat, and ranked 573rd out of 884 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Buy

Consensus Rating

Health In Tech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Health In Tech has a consensus price target of $3.25, representing about 203.7% upside from its current price of $1.07.

Amount of Analyst Coverage

Health In Tech has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Health In Tech is -53.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Health In Tech is -53.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.04% of the float of Health In Tech has been sold short.

Short Interest Ratio / Days to Cover

Health In Tech has a short interest ratio ("days to cover") of 1.69, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Health In Tech has recently increased by 21.31%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Health In Tech does not currently pay a dividend.

Dividend Growth

Health In Tech does not have a long track record of dividend growth.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.94

News Sentiment

Health In Tech has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Health In Tech this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Health In Tech insiders have not sold or bought any company stock.

Percentage Held by Insiders

77.65% of the stock of Health In Tech is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Health In Tech has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 5/13/2026
• Today: 6/13/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Insurance Agents, Brokers & Service
• Sub-Industry: Insurance
• Current Symbol: NASDAQ:HIT
• Previous Symbol: NASDAQ:HIT
• CIK: 2019505
• Web: N/A
• Phone: (888) 373-0333
• Fax: N/A
• Employees: 79
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Health In Tech: $3.25
• High Price Target: $4.00
• Low Price Target: $2.50
• Potential Upside/Downside: +203.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $34.08 million
• Price / Sales: 2.06
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 65,530,000
• Free Float: N/A
• Market Cap: $70.12 million
• Optionable: N/A
• Beta: 2.93